Retinal vascular disease: Think globally

Article

In patients with signs of retinal vascular disease, optometrists must consider the bigger picture. If a patient has hypertension, diabetes, hyperlipidemia or associated retinal changes, optometrists should be asking whether the patient has metabolic syndrome.

"Metabolic syndrome is a complex disorder with rising prevalence that is associated with significantly increased risks of cardiovascular disease and diabetes, but also with microvascular disease, including retinal complications that may put patients at risk for sight-threatening events," said Dr. Joy, Mooresville, NC.

"Therefore, in our everyday busy practices," he continued, "it is increasingly important that optometrists look at patients globally in terms of their overall systemic health and work collaboratively with our colleagues in primary care and retina to ensure that all treatable conditions are addressed and to help patients maintain optimal vision."

"Optometrists are very good at recognizing the individual pathological changes associated with diabetes, hypertension, or hypercholesterolemia. Considering the diagnosis of metabolic syndrome is a different and very important thought process," he said.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Brett Bielory, MD, at ASCRS 2025
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
© 2025 MJH Life Sciences

All rights reserved.